- Previous Close
417.00 - Open
414.00 - Bid 401.00 x --
- Ask 420.00 x --
- Day's Range
400.00 - 429.00 - 52 Week Range
391.00 - 733.00 - Volume
21,600 - Avg. Volume
14,808 - Market Cap (intraday)
2.617B - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
113.62 - EPS (TTM)
3.67 - Earnings Date Jun 12, 2025 - Jun 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Karadanote, Inc. operates family data platform business in Japan. It plans and develops applications related to pregnancy, childbirth, and childcare for medication and health management. The company also provides media planning and management services, as well as insurance agency services. In addition, it offers Mama Biyori, an app that supports pregnant women; I might be in labor, a labor pain measurement app; childbirth/childcare list for hospitalization, childbirth, and postpartum childcare; Gussurin baby, a good sleep sound app; Breastfeeding Note, a breastfeeding record management tool; Step Weaning Food, a weaning food management tool; and Vaccine Notes, a vaccination management tool. Further, the company provides blood pressure notes that record blood pressure changes; medicine notebook, which manages medication history and medication; Gussurin, a good sleep sound app; Hospital visit notes, an app that allows to manage hospital visit records; End-of-life note, an end-of-life preparation app; Aru-kun, a walking app; and Kazoku Assistant, a marketing program, as well as provision of lifestyle infrastructure services, such as household budget consultation and home water delivery services. Karadanote, Inc. was incorporated in 2008 and is headquartered in Tokyo, Japan.
corp.karadanote.jpRecent News: 4014.T
View MorePerformance Overview: 4014.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4014.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4014.T
View MoreValuation Measures
Market Cap
2.62B
Enterprise Value
2.68B
Trailing P/E
113.01
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.48
Price/Book (mrq)
8.99
Enterprise Value/Revenue
1.51
Enterprise Value/EBITDA
257.97
Financial Highlights
Profitability and Income Statement
Profit Margin
1.30%
Return on Assets (ttm)
0.84%
Return on Equity (ttm)
8.36%
Revenue (ttm)
1.77B
Net Income Avi to Common (ttm)
23M
Diluted EPS (ttm)
3.67
Balance Sheet and Cash Flow
Total Cash (mrq)
191M
Total Debt/Equity (mrq)
85.91%
Levered Free Cash Flow (ttm)
-116.5M